ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2013

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

7,727Medicare Part D Prescriptions Filled, Including Refills

Rank: 433 out of 2715

$415K Total Retail Price of All Prescriptions

Rank: 676 out of 2715

321 Patients Receiving at Least One Drug in Part D
73% Patients 65 Years and Older
49% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg 81928cdb0ebe162ff75cf405bfacadd396bf3ec84bc467b6f3e612dd63daa776 Average for
this specialty
in Michigan
Lower avg 72b1978e1dcc0b845f89d17d692cfff7aeaf8d8bce70310d8bfc535db2daf62a

Schedule Two
Controlled Substances

17% of this provider’s 321 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

24% of this provider’s 321 patients filled at least one prescription for a schedule three drug, compared to an average of 16%.

Brand Name Drugs

23% of this provider’s prescriptions were for brand-name drugs, compared to an average of 20%.

Prescription Price

$54 was the average price of a prescription from this provider, compared to $64 among peers.

Prescriptions per Patient

24 is the average number of prescriptions (including refills) per patient, compared to an average of 16.


This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

B

A benzodiazepine, or tranquilizer. More » The American Geriatrics Society says these drugs increase the risk of cognitive impairment, delirium, falls and fractures in older adults.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled with Refills Prescriptions
to 65+
Patients Recieving this Drug Category For this Prescriber For All Prescribers in
This Specialty in Michigan
HYDROCODONE-ACETAMINOPHEN 353 248 72 S3 1 1
LEVOTHYROXINE SODIUM 271 229 52 2 4
FUROSEMIDE 214 193 49 3 8
OMEPRAZOLE 212 160 60 4 5
SIMVASTATIN 204 172 45 5 2
METOPROLOL TARTRATE 194 170 47 6 10
ALPRAZOLAM 180 132 46 B 7 11
LISINOPRIL 170 122 45 8 3
METFORMIN HCL 123 55 28 9 7
ATORVASTATIN CALCIUM 120 103 31 10 9
TRAZODONE HCL 113 89 25 11 45
PREDNISONE 107 68 56 12 35
CITALOPRAM HBR 103 75 20 13 22
SERTRALINE HCL 97 92* 19 14 23
ATENOLOL 96 84 21 15 13
GABAPENTIN 94 68 21 16 14
LOSARTAN POTASSIUM 94 89* 21 16 17
LORAZEPAM 91 75 28 B 18 30
POTASSIUM CHLORIDE 90 90 12 19 19
WARFARIN SODIUM 86 86 15 20 18
HYDROCHLOROTHIAZIDE 85 65 22 21 12
QUETIAPINE FUMARATE 84 50 13 A 22 56
ENALAPRIL MALEATE 83 66 13 23 61
DONEPEZIL HCL 79 79 18 24 33
PRAVASTATIN SODIUM 78 44 19 25 16
NAMENDA 68 68 14 26 37
OXYCODONE HCL-ACETAMINOPHEN 64 32 15 S2 27 94
CLOPIDOGREL 64 53 17 27 21
SSD 63 <11 <11 29 335
ACETAMINOPHEN-CODEINE 61 <11 <11 S3 30 69
AMLODIPINE BESYLATE 60 55* 19 31 6
ALBUTEROL SULFATE 59 59 20 32 125
METOPROLOL SUCCINATE 59 <11 <11 32 20
MELOXICAM 58 39 18 34 36
DIAZEPAM 56 15 11 B 35 57
ESCITALOPRAM OXALATE 56 <11 <11 35 54
ISOSORBIDE MONONITRATE ER 55 55 16 37 43
FLUTICASONE PROPIONATE 54 19 18 38 31
ALENDRONATE SODIUM 53 48* 11 39 38
LANTUS 51 <11 <11 40 60
TRAMADOL HCL 51 34 13 40 15
VENTOLIN HFA 50 19 24 42 84
PROAIR HFA 50 15 18 42 29
About This Data

Prescribing data from Medicare’s prescription drug benefit, known as Part D, was compiled and released by the Centers for Medicare and Medicaid Services, the federal agency that oversees the program. ProPublica combined that data with additional information released by CMS. The data for 2013 includes nearly 1.4 billion prescriptions written by 1.3 million doctors, nurses and other providers. This database lists about 410,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths of these prescriptions went to patients 65 and older; the rest were for disabled patients Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to checkup@propublica.org and we will update your information. If you have other questions about this data, send a note to checkup@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Feb. 11, 2015.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.